<ol class="cite-this-references"><li id="reference-A959">Russell RG, Watts NB, Ebetino FH, Rogers MJ: Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008 Jun;19(6):733-59. doi: 10.1007/s00198-007-0540-8. [<a href="/articles/A959" target="_blank">Article</a>] </li><li id="reference-A203111">Cremers S, Drake MT, Ebetino FH, Bilezikian JP, Russell RGG: Pharmacology of bisphosphonates. Br J Clin Pharmacol. 2019 Jun;85(6):1052-1062. doi: 10.1111/bcp.13867. Epub 2019 Feb 28. [<a href="/articles/A203111" target="_blank">Article</a>] </li><li id="reference-T536">Thompson Micromedex (2004). Usp Vol I Drug Info Health Vol: Volume I (USP DI: v.1 Drug Information for the Health Care Professional) (24th ed., pp. 2475). Thompson PDR. [<a href="https://www.google.com/search?tbo=p&amp;tbm=bks&amp;q=1563634635" rel="noopener" target="_blank">ISBN:1563634635</a>] </li><li id="reference-L5864">Risedronate Sodium Tablet MSDS [<a href="https://www.greenstonellc.com/sites/default/files/pdfs/MSDS/RISEDRONATE%20SODIUM%20TABLETS%20MSDS_0.pdf" target="_blank">Link</a>] </li><li id="reference-L9179">FDA Approved Drugs: Risedronic Acid Oral Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020835s048lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L9644">FDA Approved Drug Products: Risedronic Acid Extended Release Tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022560s007lbl.pdf" target="_blank">Link</a>] </li></ol>